Type-I Interferons in Alzheimer's Disease and Other Tauopathies

Type-I Interferons in Alzheimer's Disease and Other Tauopathies

The detection of pathogen-associated molecular patterns can elicit the production of type-I interferons (IFNs), soluble cytokines that induce a transcriptional state inhibitory to viral replication. Signatures of type-I IFN-driven gene expression, and type-I IFNs themselves, are observed in the cent...

Full description

Bibliographic Details
Main Authors:	Sophie A. I. Sanford, William A. McEwan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	type-I interferon response Alzheimer's disease tauopathies innate immunity antiviral immunity IFN
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2022.949340/full

Similar Items

Interferon-Independent Innate Responses to Cytomegalovirus
by: Caroline L. Ashley, et al.
Published: (2019-12-01)

Evasion of interferon-mediated immune response by arteriviruses
by: Zhijie Jian, et al.
Published: (2022-08-01)

Brain derived β-interferon is a potential player in Alzheimer’s disease pathogenesis and cognitive impairment
by: Qiong Wang, et al.
Published: (2024-12-01)

Genome-Wide Classification of Type I, Type II and Type III Interferon-Stimulated Genes in Chicken Fibroblasts
by: Diwakar Santhakumar, et al.
Published: (2019-10-01)

Interferon Signaling in Chickens Plays a Crucial Role in Inhibiting Influenza Replication in DF1 Cells
by: Daniel S. Layton, et al.
Published: (2022-01-01)

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling
by: John Grayson Evans, et al.
Published: (2023-02-01)

Forms and Methods for Interferon’s Encapsulation
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)

The role of type 1 interferon in systemic sclerosis
by: Minghua eWu, et al.
Published: (2013-09-01)

Emerging Role of Interferon-Induced Noncoding RNA in Innate Antiviral Immunity
by: Jie Min, et al.
Published: (2022-11-01)

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
by: Alessandra Pierangeli, et al.
Published: (2022-07-01)

Mosquito-borne flaviviruses and type I interferon: catch me if you can!
by: Jim Zoladek, et al.
Published: (2023-10-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
by: A. A. Shuldyakov, et al.
Published: (2020-05-01)

Avian Interferon-Inducible Transmembrane Protein Family Effectively Restricts Avian Tembusu Virus Infection
by: Ji-Long Chen, et al.
Published: (2017-04-01)

Antiviral Functions of Type I and Type III Interferons in the Olfactory Epithelium
by: Ahmad Zedan, et al.
Published: (2023-12-01)

Neuroimmune proteins can differentiate between tauopathies
by: Jonathan D. Cherry, et al.
Published: (2022-11-01)

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
by: Alaa A. Abdelmageed, et al.
Published: (2024-12-01)

Virus-like particle – mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection
by: Enrico Palermo, et al.
Published: (2022-12-01)

The Molecular Interactions of ZIKV and DENV with the Type-I IFN Response
by: Rosa C. Coldbeck-Shackley, et al.
Published: (2020-09-01)

The Role of RNA Sensors in Regulating Innate Immunity to Gammaherpesviral Infections
by: Huirong Zhang, et al.
Published: (2023-06-01)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
by: Geraldine Zimmer-Bensch, et al.
Published: (2021-11-01)

Current progress on innate immune evasion mediated by Npro protein of pestiviruses
by: Shubo Wen, et al.
Published: (2023-04-01)

Virus Infections and Interferon Inductors in the Complex Therapy
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Antiviral effects of interferon-stimulated genes in bats
by: Dan Zhang, et al.
Published: (2023-08-01)

Fine-Tuning of Type I Interferon Response by STAT3
by: Ming-Hsun Tsai, et al.
Published: (2019-06-01)

Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer’s disease
by: George D. Vavougios, et al.
Published: (2024-03-01)

Interference without interferon: interferon-independent induction of interferon-stimulated genes and its role in cellular innate immunity
by: Shachee Swaraj, et al.
Published: (2024-10-01)

Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d
by: Rohit Chandwani, et al.
Published: (2023-05-01)

Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
by: Giulia Finotti, et al.
Published: (2017-08-01)

The regulation of antiviral activity of interferon epsilon
by: Fu-Rong Zhao, et al.
Published: (2022-10-01)

Heparan Sulfate Proteoglycans in Tauopathy
by: Yanan Zhu, et al.
Published: (2022-11-01)

Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01)

The Pestivirus RNase E<sup>rns</sup> Tames the Interferon Response of the Respiratory Epithelium
by: Guillaume Beilleau, et al.
Published: (2024-12-01)

Dexamethasone impairs the expression of antimicrobial mediators in lipopolysaccharide-activated primary macrophages by inhibiting both expression and function of interferon β
by: John D. O’Neil, et al.
Published: (2023-10-01)

Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response
by: Luhong Cao, et al.
Published: (2023-09-01)

A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects
by: Ji Xiao, et al.
Published: (2022-03-01)

Interferon and autoantigens: intersection in autoimmunity
by: Brendan Antiochos, et al.
Published: (2023-05-01)

Mutual regulations between Toxoplasma gondii and type I interferon
by: Lingling Song, et al.
Published: (2024-07-01)

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
by: Bin Zhang, et al.
Published: (2018-11-01)

“Toll-free” pathways for production of type I interferons
by: Ling Wang, et al.
Published: (2017-11-01)

Reduced sputum expression of interferon-stimulated genes in severe COPD
by: Hilzendeger C, et al.
Published: (2016-06-01)